Park Place Capital’s Eli Lilly LLY Stock Holding History

Park Place Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$778K	Buy	846 +162	+24%	+$164K	0.16%	88
2025 Q4	$735K	Buy	684 +7	+1%	+$6.69K	0.15%	94
2025 Q3	$517K	Sell	677 -156	-19%	-$116K	0.11%	119
2025 Q2	$646K	Sell	833 -954	-53%	-$741K	0.15%	104
2025 Q1	$1.48M	Sell	1,787 -39	-2%	-$32.5K	0.4%	55
2024 Q4	$1.41M	Sell	1,826 -56	-3%	-$46.4K	0.39%	56
2024 Q3	$1.67M	Sell	1,882 -466	-20%	-$419K	0.48%	45
2024 Q2	$2.13M	Sell	2,348 -444	-16%	-$355K	0.68%	33
2024 Q1	$2.17M	Sell	2,792 -246	-8%	-$175K	0.78%	29
2023 Q4	$1.77M	Sell	3,038 -3	-0.1%	-$1.75K	0.71%	30
2023 Q3	$1.63M	Buy	3,041 +496	+19%	+$256K	0.48%	45
2023 Q2	$1.19M	Sell	2,545 -943	-27%	-$395K	0.34%	65
2023 Q1	$1.2M	Buy	3,488 +429	+14%	+$145K	0.34%	67
2022 Q4	$1.12M	Buy	+3,059	New	+$1.08M	0.32%	76

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Park Place Capital's LLY Position: Q1 2026 in Review

Park Place Capital increased its Eli Lilly (LLY) stake by 24% in Q1 2026, buying an estimated $164K and bringing the position to 846 shares worth $778K. The position accounts for 0.16% of the portfolio, ranked #88.

Park Place Capital first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.17M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Park Place Capital held 846 shares of Eli Lilly worth $778K as of Q1 2026.
Park Place Capital bought 162 Eli Lilly shares in Q1 2026, an estimated $164K.
Eli Lilly made up 0.16% of Park Place Capital's portfolio in Q1 2026, its #88 holding.
Park Place Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
Park Place Capital's Eli Lilly position peaked at $2.17M in Q1 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.